The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Clinical diagnosis and staging of cholangiocarcinoma
Open accessAbstract
Cholangiocarcinoma is the most frequent biliary malignancy. It is difficult to diagnose owing to its anatomic location, growth patterns and lack of definite diagnostic criteria. Currently, cholangiocarcinoma is classified into the following types according to its anatomic location along the biliary tree: intrahepatic, perihilar or distal extrahepatic cholangiocarcinoma. These cholangiocarcinoma types differ in their biological behavior and management. The appropriate stratification of patients with regard to the anatomic location and stage of cholangiocarcinoma is a key determinate in their management. Staging systems can guide this stratification and provide prognostic information. In addition, staging systems are essential in order to compare and contrast the outcomes of different therapeutic approaches. A number of staging systems exist for cholangiocarcinoma—several early ones have been updated, and new ones are being developed. We discuss the emerging diagnostic criteria as well as the different staging systems for cholangiocarcinoma, and provide a critical appraisal regarding these advances in biliary tract malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2011) · Hepatogastroenterology · doi:10.5754/hge11125 · Cited by 2,450
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
Jarnagin, W. R., Fong, Y., DeMatteo, R. P., Gonen, M., Burke, E. C., Bodniewicz, J., Youssef, M., Klimstra, D., & Blumgart, L. H. (2001) · Annals of Surgery · doi:10.1097/00000658-200110000-00010 · Cited by 1,347
Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution
DeOliveira, M. L., Cunningham, S. C., Cameron, J. L., Kamangar, F., Winter, J. M., Lillemoe, K. D., Choti, M. A., Yeo, C. J., & Schulick, R. D. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251366.62632.d3 · Cited by 1,300
Cholangiocarcinoma: A Spectrum of Intrahepatic, Perihilar, and Distal Tumors
Nakeeb, A., Pitt, H. A., Sohn, T. A., Coleman, J., Abrams, R. A., Piantadosi, S., Hruban, R. H., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00005 · Cited by 1,187
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
Ghazale, A., Chari, S. T., Zhang, L., Smyrk, T. C., Takahashi, N., Levy, M. J., Topazian, M. D., Clain, J. E., Pearson, R. K., Petersen, B. T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.009 · Cited by 890
Endo, I., Gonen, M., Yopp, A. C., Dalal, K. M., Zhou, Q., Klimstra, D., D'Angelica, M., DeMatteo, R. P., Fong, Y., Schwartz, L., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318176c4d3 · Cited by 865
Management Strategies in Resection for Hilar Cholangiocarcinoma
BISMUTH, H., NAKACHE, R., & DIAMOND, T. (1992) · Annals of Surgery · doi:10.1097/00000658-199201000-00005 · Cited by 807
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.
Bismuth, H., & Corlette, M. B. (1975) · PubMed · Cited by 751
Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
Everhart, J. E., & Ruhl, C. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.038 · Cited by 710
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Blechacz, B., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22310 · Cited by 681
Self-citationIncidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K., Angulo, P., Pasha, T. M., Egan, K., Petz, J., & Lindor, K. D. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 557
Patel, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00744-3 · Cited by 425
Welzel, T. M., McGlynn, K. A., Hsing, A. W., O'Brien, T. R., & Pfeiffer, R. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj234 · Cited by 372
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
Komuta, M., Spee, B., Borght, S. V., De Vos, R., Verslype, C., Aerts, R., Yano, H., Suzuki, T., Matsuda, M., Fujii, H., et al. (2008) · Hepatology · doi:10.1002/hep.22238 · Cited by 363
Self-citationLevy, C., Lymp, J., Angulo, P., Gores, G. J., Larusso, N., & Lindor, K. D. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2927-8 · Cited by 339 · cited 1×
“In patients with PSC, the sensitivity and specificity of CA 19-9 is 79% and 98%, respectively, at a serum concentration of >129 U/ml”
BackgroundSelf-citationVilana, R., Forner, A., Bianchi, L., García-Criado, Á., Rimola, J., de Lope, C. R., Reig, M., Ayuso, C., Brú, C., & Bruix, J. (2010) · Hepatology · doi:10.1002/hep.23600 · Cited by 318
New staging system and a registry for perihilar cholangiocarcinoma
DeOliveira, M. L., Schulick, R. D., Nimura, Y., Rosen, C., Gores, G., Neuhaus, P., & Clavien, P.-A. (2011) · Hepatology · doi:10.1002/hep.24227 · Cited by 318
Self-citationAccurate preoperative evaluation of liver mass lesions without fine-needle biopsy
Torzilli, G., Minagawa, M., Takayama, T., Inoue, K., Hui, A.-M., Kubota, K., Ohtomo, K., & Makuuchi, M. (1999) · Hepatology · doi:10.1002/hep.510300411 · Cited by 316
A Proposed Staging System for Intrahepatic Cholangiocarcinoma
Nathan, H., Aloia, T. A., Vauthey, J.-N., Abdalla, E. K., Zhu, A. X., Schulick, R. D., Choti, M. A., & Pawlik, T. M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0180-z · Cited by 314
Choi, S.-B., Kim, K.-S., Choi, J.-Y., Park, S.-W., Choi, J.-S., Lee, W.-J., & Chung, J.-B. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0631-1 · Cited by 304
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
Komuta, M., Borght, S. V., Kojiro, M., Aerts, R., & Roskams, T. (2007) · Cited by 301
Self-citationRimola, J., Forner, A., Reig, M., Vilana, R., de Lope, C. R., Ayuso, C., & Bruix, J. (2009) · Hepatology · doi:10.1002/hep.23071 · Cited by 298
Corvera, C. U., Blumgart, L. H., Akhurst, T., DeMatteo, R. P., D’Angelica, M., Fong, Y., & Jarnagin, W. R. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.002 · Cited by 292
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors.
Klempnauer, J., Ridder, G. J., von Wasielewski, R., Werner, M., Weimann, A., & Pichlmayr, R. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.947 · Cited by 286
Nakanuma, Y., Hoso, M., Sanzen, T., & Sasaki, M. (1997) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19970915)38:6<552::aid-jemt2>3.0.co;2-h · Cited by 281
Kluge, R., Schmidt, F., Caca, K., Barthel, H., Hesse, S., Georgi, P., Seese, A., Huster, D., & Berr, F. (2001) · Hepatology · doi:10.1053/jhep.2001.23912 · Cited by 265
Outcomes After Curative Resections of Cholangiocarcinoma
Nagorney, D. M. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420200045008 · Cited by 246
Heimbach, J. K., Gores, G. J., Haddock, M. G., Alberts, S. R., Pedersen, R., Kremers, W., Nyberg, S. L., Ishitani, M. B., & Rosen, C. B. (2006) · Transplantation · doi:10.1097/01.tp.0000253551.43583.d1 · Cited by 213
Self-citationPark, J., Kim, M.-H., Kim, K.-P., Park, D. H., Moon, S.-H., Song, T. J., Eum, J., Lee, S. S., Seo, D. W., & Lee, S. K. (2009) · Gut and Liver · doi:10.5009/gnl.2009.3.4.298 · Cited by 193
Vestergaard, E. M., Hein, H. O., Meyer, H., Grunnet, N., Jørgensen, J. B., Wolf, H., & Orntoft, T. F. (1999) · PubMed · Cited by 164
Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer
Kato, T., Tsukamoto, E., Kuge, Y., Katoh, C., Nambu, T., Nobuta, A., Kondo, S., Asaka, M., & Tamaki, N. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0852-z · Cited by 117
Intrahepatic Cholangiocarcinoma
Poultsides, G. A., Zhu, A. X., Choti, M. A., & Pawlik, T. M. (2010) · Surgical Clinics of North America · doi:10.1016/j.suc.2010.04.011 · Cited by 117
Fluorescence in situ hybridization in diagnostic cytology
Halling, K. C., & Kipp, B. R. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.04.015 · Cited by 116
Masselli, G., Manfredi, R. M., Vecchioli, A., & Gualdi, G. (2008) · European Radiology · doi:10.1007/s00330-008-1004-z · Cited by 107
Staging cholangiocarcinoma by imaging studies
Vilgrain, V. (2008) · HPB · doi:10.1080/13651820801992617 · Cited by 98
High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma
Aloia, T. A., Charnsangavej, C., Faria, S. C., Ribero, D., Abdalla, E. K., Vauthey, J. N., & Curley, S. A. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2006.10.024 · Cited by 93
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma
Uenishi, T., Yamazaki, O., Tanaka, H., Takemura, S., Yamamoto, T., Tanaka, S., Nishiguchi, S., & Kubo, S. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9650-y · Cited by 86
Vogl, T. J., Schwarz, W., Heller, M., Herzog, C., Zangos, S., Hintze, R. E., Neuhaus, P., & Hammerstingl, R. (2006) · European Radiology · doi:10.1007/s00330-005-0139-4 · Cited by 79
Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
Uenishi, T., Kubo, S., Hirohashi, K., Tanaka, H., Shuto, T., Yamamoto, T., & Nishiguchi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601026 · Cited by 71
Cholangiocarcinoma: The Impact of Tumor Location and Treatment Strategy on Outcome
Heron, D. E., Stein, D. E., Eschelman, D. J., et al. (2003) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000026833.73428.1f · Cited by 69
Extraordinarily Elevated Ca19-9 in Benign Conditions: A Case Report and Review of the Literature
Akdoğran, M., Şaşmaz, N., Kayhan, B., Bıyıkoğrlu, I., Dışıbeyaz, S., & Şahın, B. (2001) · Tumori Journal · doi:10.1177/030089160108700513 · Cited by 66
Zervos, E. E., Osborne, D., Goldin, S. B., et al. (2005) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2005.07.025 · Cited by 60
DeHaan, R. D., Kipp, B. R., Smyrk, T. C., Abraham, S. C., Roberts, L. R., & Halling, K. C. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.09.004 · Cited by 58
A conceptual proposal for staging ductal cholangiocarcinoma
Blechacz, B. R. A., Sánchez, W., & Gores, G. J. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283292383 · Cited by 44
Self-citationPositron Emission Tomography Scan for a Hepatic Mass
Blechacz, B. R. A., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.24002 · Cited by 25
Self-citationHepatic MR Imaging Using Ferumoxides
Raman, S. S., Lu, D., Chen, S. C., et al. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.4.1770807 · Cited by 22
Cited by
Razumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Self-citationGuidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Self-citationBanales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Ilyas, S. I., & Gores, G. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.013 · Cited by 1,307
Self-citationBrindley, P. J., Bachini, M., Ilyas, S. I., Khan, S. A., Loukas, A., Sirica, A. E., Teh, B. T., Wongkham, S., & Gores, G. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00300-2 · Cited by 841
Self-citation
Metadata
- Authors
- Blechacz, B., Komuta, M., Roskams, T., & Gores, G. J.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2011-08-02
- Volume
- 8
- Issue
- 9
- Pages
- 512-522
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W1992149176
- Cited by
- 747
- References
- 46
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.